ESR1 and breast carcinoma: Furthermore, it is a well-known fact that levels of Estrogen Receptor (ER) impacting breast cancer metastasis are the fundamental and critical determinants of clinical outcomes (Kammerer et al., 2013; Gamucci et al., 2013).